Table IV.
Mean (SD) values for intraocular pressure (IOP) and pulsatile ocular blood flow (pOBF) by treatment group at baseline and throughout the study.∗†
| Time Point | Travoprost | Latanoprost |
|---|---|---|
| Baseline | ||
| IOP | 23.7(2.8) | 24.1(2.9) |
| pOBF | 709.8(284.1) | 680.8(88.4) |
| Day 15 | ||
| IOP | 18.2(3.2) | 18.6(3.7) |
| pOBF | 1028.3(447.5)‡ | 1006.6(57.7) |
| Day 30 | ||
| IOP | 17.4(2.0) | 17.3(1.8) |
| pOBF | 1026.8 (438.9)‡ | 958.6(66.0) |
| Day 60 | ||
| IOP | 16.3(2.0) | 16.7(1.5) |
| pOBF | 1103.7(434.7) | 958.9(86.6) |
| Day 90 | ||
| IOP | 16.1(1.9) | 16.0(1.5) |
| pOBF | 1060.1(343.4)§ | 926.3(63.0) |
| Day 180 | ||
| IOP | 16.1(1.9) | 16.5(1.7) |
| pOBF | 923.8(240.4)§ | 833.8(85.9) |
No statistically significant between-group differences were found (unpaired t-test).
P<0.01 versus baseline (Dunnett multiple comparison test) unless otherwise indicated.
P=NS versus baseline.
P<0.05 versus baseline.